Verified factor-similar pair

FYC vs XSMO

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB UMD
Similarity score
89
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • FYC has the higher backtested relative Sharpe (1.181 vs 1.041).
  • XSMO has the lower published fee (0.36% vs 0.70%).
  • FYC is cheaper on dividend valuation (68 vs 126, where 100 is each fund's historical median).
  • FYC has the stronger regression fit (adjusted R-squared 0.954 vs 0.903).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

FYC

First Trust Small Cap Growth AlphaDEX Fund
SMB UMD
Adj. R2
0.954
Rel. Sharpe
1.181
Mkt beta
1.06
AUM
US$951M
MER
0.70%
Valuation
68

XSMO

Invesco S&P SmallCap Momentum ETF
SMB UMD
Adj. R2
0.903
Rel. Sharpe
1.041
Mkt beta
0.99
AUM
US$2.5B
MER
0.36%
Valuation
126

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
FYC
+0.95
|t|
+22.6
XSMO
+0.84
|t|
+17.4
diff +0.12
HML
FYC
-0.04
|t|
-0.9
XSMO
+0.03
|t|
+0.5
diff -0.06
RMW
FYC
-0.10
|t|
-2.1
XSMO
+0.03
|t|
+0.6
diff -0.13
CMA
FYC
-0.02
|t|
-0.3
XSMO
-0.04
|t|
-0.6
diff +0.03
UMD
FYC
+0.24
|t|
+8.1
XSMO
+0.22
|t|
+7.7
diff +0.02

Why This Pair Matches

Exposure level
89
Exposure shape
99
Mkt beta diff
0.07
Rel. Sharpe diff
0.141

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

FYC fund page XSMO fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.